| Host: |
Rabbit |
| Applications: |
IHC/IF/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-C-C motif chemokine 7 (50-99 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IHC-P 1:50-200ELISA 1:10000-20000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
CCL7 |
| Gene ID: |
6354 |
| Uniprot ID: |
CCL7_HUMAN |
| Immunogen Region: |
50-99 aa |
| Specificity: |
The antibody detects endogenous MCP-3 |
| Immunogen: |
Synthetic peptide from the human protein at the amino acid range 50-99 |
| Function | Chemotactic factor that attracts monocytes and eosinophils, but not neutrophils. Augments monocyte anti-tumor activity. Also induces the release of gelatinase B. This protein can bind heparin. Binds to CCR1, CCR2 and CCR3. |
| Protein Name | C-C Motif Chemokine 7Monocyte Chemoattractant Protein 3Monocyte Chemotactic Protein 3Mcp-3Nc28Small-Inducible Cytokine A7 |
| Database Links | Reactome: R-HSA-380108 |
| Cellular Localisation | Secreted |
| Alternative Antibody Names | Anti-C-C Motif Chemokine 7 antibodyAnti-Monocyte Chemoattractant Protein 3 antibodyAnti-Monocyte Chemotactic Protein 3 antibodyAnti-Mcp-3 antibodyAnti-Nc28 antibodyAnti-Small-Inducible Cytokine A7 antibodyAnti-CCL7 antibodyAnti-MCP3 antibodyAnti-SCYA6 antibodyAnti-SCYA7 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
